Ashling Wahner

bordentown, new jersey, united states

Publications:

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

About

Editor for OncLive at MJH Life Sciences. Produces OncLive's podcast, OncLive On Air, and helps ensure timely publication of news content and announcements from the FDA approval pipeline.

Featured Articles

Zolbetuximab Plus Chemo and Nivolumab Yields Efficacy in mG/GEJ Cancer

News|Articles|January 9, 2026 Zolbetuximab Plus Chemo and Nivolumab Yields Efficacy in mG/GEJ Cancer Author(s) Ashling WahnerFact checked by: Courtney FlahertyZolbetuximab plus mFOLFOX6 and nivolumab led to meaningful gains in patients with unresectable g... See more

oncnursingnews.com•Ashling Wahner•Jan 9, 2026

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

Articles1

Last Article4 days ago

Stats

Education

Bachelor Of Arts, Dance, English at Muhlenberg CollegeGraduated: 2021

Education

Ashling Wahner

Is this you?

About

Featured Articles

Zolbetuximab Plus Chemo and Nivolumab Yields Efficacy in mG/GEJ Cancer

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Social Media

Featured Articles

Zolbetuximab Plus Chemo and Nivolumab Yields Efficacy in mG/GEJ Cancer

Education